IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-31196-5.html
   My bibliography  Save this article

Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques

Author

Listed:
  • Victoria E. K. Walker-Sperling

    (Beth Israel Deaconess Medical Center)

  • Noe B. Mercado

    (Beth Israel Deaconess Medical Center)

  • Abishek Chandrashekar

    (Beth Israel Deaconess Medical Center)

  • Erica N. Borducchi

    (Beth Israel Deaconess Medical Center)

  • Jinyan Liu

    (Beth Israel Deaconess Medical Center)

  • Joseph P. Nkolola

    (Beth Israel Deaconess Medical Center)

  • Mark Lewis

    (Bioqual)

  • Jeffrey P. Murry

    (Gilead Sciences)

  • Yunling Yang

    (Gilead Sciences)

  • Romas Geleziunas

    (Gilead Sciences)

  • Merlin L. Robb

    (Walter Reed Army Institute of Research)

  • Nelson L. Michael

    (Walter Reed Army Institute of Research)

  • Maria G. Pau

    (Janssen Vaccines & Prevention)

  • Frank Wegmann

    (Janssen Vaccines & Prevention)

  • Hanneke Schuitemaker

    (Janssen Vaccines & Prevention)

  • Emily J. Fray

    (Johns Hopkins University School of Medicine)

  • Mithra R. Kumar

    (Johns Hopkins University School of Medicine)

  • Janet D. Siliciano

    (Johns Hopkins University School of Medicine)

  • Robert F. Siliciano

    (Johns Hopkins University School of Medicine)

  • Dan H. Barouch

    (Beth Israel Deaconess Medical Center
    Ragon Institute of MGH, MIT, and Harvard)

Abstract

The latent viral reservoir is the critical barrier for developing an HIV-1 cure. Previous studies have shown that therapeutic vaccination or broadly neutralizing antibody (bNAb) administration, together with a Toll-like receptor 7 (TLR7) agonist, enhanced virologic control or delayed viral rebound, respectively, following discontinuation of antiretroviral therapy (ART) in SIV- or SHIV-infected rhesus macaques. Here we show that the combination of active and passive immunization with vesatolimod may lead to higher rates of post-ART virologic control compared to either approach alone. Therapeutic Ad26/MVA vaccination and PGT121 administration together with TLR7 stimulation with vesatolimod resulted in 70% post-ART virologic control in SHIV-SF162P3-infected rhesus macaques. These data suggest the potential of combining active and passive immunization targeting different immunologic mechanisms as an HIV-1 cure strategy.

Suggested Citation

  • Victoria E. K. Walker-Sperling & Noe B. Mercado & Abishek Chandrashekar & Erica N. Borducchi & Jinyan Liu & Joseph P. Nkolola & Mark Lewis & Jeffrey P. Murry & Yunling Yang & Romas Geleziunas & Merlin, 2022. "Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31196-5
    DOI: 10.1038/s41467-022-31196-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-31196-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-022-31196-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Erica N. Borducchi & Jinyan Liu & Joseph P. Nkolola & Anthony M. Cadena & Wen-Han Yu & Stephanie Fischinger & Thomas Broge & Peter Abbink & Noe B. Mercado & Abishek Chandrashekar & David Jetton & Laur, 2018. "Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys," Nature, Nature, vol. 563(7731), pages 360-364, November.
    2. Erica N. Borducchi & Crystal Cabral & Kathryn E. Stephenson & Jinyan Liu & Peter Abbink & David Ng’ang’a & Joseph P. Nkolola & Amanda L. Brinkman & Lauren Peter & Benjamin C. Lee & Jessica Jimenez & D, 2016. "Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys," Nature, Nature, vol. 540(7632), pages 284-287, December.
    3. Yoshiaki Nishimura & Rajeev Gautam & Tae-Wook Chun & Reza Sadjadpour & Kathryn E. Foulds & Masashi Shingai & Florian Klein & Anna Gazumyan & Jovana Golijanin & Mitzi Donaldson & Olivia K. Donau & Rona, 2017. "Early antibody therapy can induce long-lasting immunity to SHIV," Nature, Nature, vol. 543(7646), pages 559-563, March.
    4. Anthony M. Cadena & John D. Ventura & Peter Abbink & Erica N. Borducchi & Hubert Tuyishime & Noe B. Mercado & Victoria Walker-Sperling & Mazuba Siamatu & Po-Ting Liu & Abishek Chandrashekar & Joseph P, 2021. "Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    5. Erica N. Borducchi & Jinyan Liu & Joseph P. Nkolola & Anthony M. Cadena & Wen-Han Yu & Stephanie Fischinger & Thomas Broge & Peter Abbink & Noe B. Mercado & Abishek Chandrashekar & David Jetton & Laur, 2018. "Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys," Nature, Nature, vol. 564(7734), pages 8-8, December.
    6. James B. Whitney & Alison L. Hill & Srisowmya Sanisetty & Pablo Penaloza-MacMaster & Jinyan Liu & Mayuri Shetty & Lily Parenteau & Crystal Cabral & Jennifer Shields & Stephen Blackmore & Jeffrey Y. Sm, 2014. "Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys," Nature, Nature, vol. 512(7512), pages 74-77, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Miriam Rosás-Umbert & Jesper D. Gunst & Marie H. Pahus & Rikke Olesen & Mariane Schleimann & Paul W. Denton & Victor Ramos & Adam Ward & Natalie N. Kinloch & Dennis C. Copertino & Tuixent Escribà & An, 2022. "Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    2. Xiaolei Wang & Eunice Vincent & Summer Siddiqui & Katherine Turnbull & Hong Lu & Robert Blair & Xueling Wu & Meagan Watkins & Widade Ziani & Jiasheng Shao & Lara A. Doyle-Meyers & Kasi E. Russell-Lodr, 2022. "Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    3. Daniel B. Reeves & Bryan T. Mayer & Allan C. deCamp & Yunda Huang & Bo Zhang & Lindsay N. Carpp & Craig A. Magaret & Michal Juraska & Peter B. Gilbert & David C. Montefiori & Katharine J. Bar & E. Fab, 2023. "High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    4. Caroline Passaes & Delphine Desjardins & Anaïs Chapel & Valérie Monceaux & Julien Lemaitre & Adeline Mélard & Federico Perdomo-Celis & Cyril Planchais & Maël Gourvès & Nastasia Dimant & Annie David & , 2024. "Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    5. Jinhee Kim & Deepanwita Bose & Mariluz Araínga & Muhammad R. Haque & Christine M. Fennessey & Rachel A. Caddell & Yanique Thomas & Douglas E. Ferrell & Syed Ali & Emanuelle Grody & Yogesh Goyal & Clau, 2024. "TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    6. Omolara O. Baiyegunhi & Jaclyn Mann & Trevor Khaba & Thandeka Nkosi & Anele Mbatha & Funsho Ogunshola & Caroline Chasara & Nasreen Ismail & Thandekile Ngubane & Ismail Jajbhay & Johan Pansegrouw & Kri, 2022. "CD8 lymphocytes mitigate HIV-1 persistence in lymph node follicular helper T cells during hyperacute-treated infection," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    7. Christoph Kreer & Cosimo Lupo & Meryem S. Ercanoglu & Lutz Gieselmann & Natanael Spisak & Jan Grossbach & Maike Schlotz & Philipp Schommers & Henning Gruell & Leona Dold & Andreas Beyer & Armita Nourm, 2023. "Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals," Nature Communications, Nature, vol. 14(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-31196-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.